Literature DB >> 25589921

P21-Activated Kinase 4 (PAK4) Inhibitors as Potential Cancer Therapy.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2014        PMID： 25589921      PMCID： PMC4291721          DOI： 10.1021/ml500445c

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  3 in total

Review 1.  p21-Activated kinase inhibitors: a patent review.

Authors:  James J Crawford; Klaus P Hoeflich; Joachim Rudolph
Journal:  Expert Opin Ther Pat       Date:  2012-03-11       Impact factor: 6.674

Review 2.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

Review 3.  Role of p-21-activated kinases in cancer progression.

Authors:  Helen King; Nicole S Nicholas; Claire M Wells
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813
  3 in total
  2 in total

1.  Release of transcriptional repression via ErbB2-induced, SUMO-directed phosphorylation of myeloid zinc finger-1 serine 27 activates lysosome redistribution and invasion.

Authors:  Ditte Marie Brix; Siri Amanda Tvingsholm; Malene Bredahl Hansen; Knut Bundgaard Clemmensen; Tiina Ohman; Valentina Siino; Matteo Lambrughi; Klaus Hansen; Pietri Puustinen; Irina Gromova; Peter James; Elena Papaleo; Markku Varjosalo; José Moreira; Marja Jäättelä; Tuula Kallunki
Journal:  Oncogene       Date:  2019-01-08       Impact factor: 9.867

2.  Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity.

Authors:  Tianxiao Wu; Yu Pang; Jing Guo; Wenbo Yin; Mingyue Zhu; Chenzhou Hao; Kai Wang; Jian Wang; Dongmei Zhao; Maosheng Cheng
Journal:  Molecules       Date:  2018-02-14       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.